Atlas Trials

Olmutinib Trial in T790M (+) NSCLC Patients Detected by Liquid Biopsy Using BALF Extracellular Vesicular DNA

Clinical trial NCT03228277 · COMPLETED

Trial details

NCT number
NCT03228277
Sponsor
Konkuk University Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non Small Cell Lung Cancer
Start date
2017-07-17
Primary completion
2018-07-31
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.